9MW2821 Combined With Other Antitumor Drugs in Patients With Advanced Gynecological Tumors
Clinical trial NCT06926998 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06926998
- Sponsor
- Mabwell (Shanghai) Bioscience Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-04-15
- Primary completion
- 2027-05-01
- Enrollment
- 260
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.